# Modulating Surgery-Induced Blood-Brain Barrier Disruption in Elderly

> **NCT06090955** · NA · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 108 (estimated)

## Conditions studied

- Delirium, Postoperative

## Interventions

- **DRUG:** Dexmedetomidine Injection [Precedex]
- **DRUG:** Lidocaine IV
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT06090955
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-25
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06090955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06090955, "Modulating Surgery-Induced Blood-Brain Barrier Disruption in Elderly". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06090955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*